CELU
Celularity partners for peptide drug API production
Celularity agreed to manufacture peptide APIs for Vesalius in a long-term collaboration.
CELU news
Latest 5 stories · newest Oct 29, 2026
CELU
Celularity appoints Naveen Jain to board of directors
Celularity has named Naveen Jain, CEO of Viome, to its Board of Directors. This addition reflects the company's strategic pivot toward a more consumer-focused approach to regenerative medicine.
CELU
Celularity provides note financing terms
Celularity Inc. has issued a senior secured convertible promissory note. The note allows conversion at $1.50 per share and was issued on September 23, 2026.
CELU
Celularity enters $1M loan agreement with Barach Family Trust
Celularity Inc. executed a $1 million loan agreement with the Philip & Daniele Barach Family Trust carrying a 4.0% interest rate. This private financing event boosts the biotech firm's available liquidity.
CELU
Celularity appoints Rick Gonzalez as Chief Commercial Officer
Celularity Inc appointed Rick Gonzalez as Chief Commercial Officer effective May 29, 2026, to lead global commercialization of cenplacel-L and Lifebank. The appointment supports the company's revenue-generating strategy in the regenerative medicine market, leveraging Gonzalez's 20+ years of biotech …
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same CELU feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/CELU/newsSTART FREE